Logo image of CHSN

CHANSON INTERNATIONAL HOLD-A (CHSN) Stock Fundamental Analysis

NASDAQ:CHSN - KYG2104U1076 - Common Stock

2.17 USD
-0.08 (-3.77%)
Last: 9/3/2025, 8:05:52 PM
2.16 USD
-0.01 (-0.46%)
Pre-Market: 9/4/2025, 4:49:29 AM
Fundamental Rating

4

CHSN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of CHSN is average, but there are quite some concerns on its profitability. CHSN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CHSN had positive earnings in the past year.
In the past year CHSN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHSN reported negative net income in multiple years.
CHSN had a positive operating cash flow in 4 of the past 5 years.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

CHSN has a Return On Assets of 1.81%. This is in the lower half of the industry: CHSN underperforms 60.98% of its industry peers.
CHSN has a Return On Equity of 4.10%. This is in the lower half of the industry: CHSN underperforms 60.98% of its industry peers.
Industry RankSector Rank
ROA 1.81%
ROE 4.1%
ROIC N/A
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

CHSN has a better Profit Margin (4.15%) than 85.37% of its industry peers.
In the last couple of years the Profit Margin of CHSN has declined.
CHSN has a better Gross Margin (39.47%) than 90.24% of its industry peers.
In the last couple of years the Gross Margin of CHSN has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 4.15%
GM 39.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

6

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHSN has less shares outstanding
CHSN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CHSN has an improved debt to assets ratio.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that CHSN is in the distress zone and has some risk of bankruptcy.
CHSN has a worse Altman-Z score (0.62) than 85.37% of its industry peers.
CHSN has a debt to FCF ratio of 0.51. This is a very positive value and a sign of high solvency as it would only need 0.51 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.51, CHSN belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
CHSN has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CHSN (0.08) is better than 78.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.51
Altman-Z 0.62
ROIC/WACCN/A
WACC6.83%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.30 indicates that CHSN should not have too much problems paying its short term obligations.
CHSN has a Current ratio of 1.30. This is in the better half of the industry: CHSN outperforms 68.29% of its industry peers.
A Quick Ratio of 1.25 indicates that CHSN should not have too much problems paying its short term obligations.
The Quick ratio of CHSN (1.25) is better than 80.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.25
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

CHSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 542.07%, which is quite impressive.
CHSN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.68% yearly.
CHSN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.65%.
Measured over the past years, CHSN shows a small growth in Revenue. The Revenue has been growing by 7.70% on average per year.
EPS 1Y (TTM)542.07%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%277.28%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%26.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CHSN is valuated cheaply with a Price/Earnings ratio of 0.72.
Based on the Price/Earnings ratio, CHSN is valued cheaper than 95.12% of the companies in the same industry.
CHSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.84.
Industry RankSector Rank
PE 0.72
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than CHSN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.84
EV/EBITDA -3.28
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (9/3/2025, 8:05:52 PM)

Premarket: 2.16 -0.01 (-0.46%)

2.17

-0.08 (-3.77%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.32%
Inst Owner ChangeN/A
Ins Owners19.52%
Ins Owner ChangeN/A
Market Cap2.47M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.72
Fwd PE N/A
P/S 0.14
P/FCF 0.84
P/OCF 0.7
P/B 0.13
P/tB 0.14
EV/EBITDA -3.28
EPS(TTM)3.02
EY139.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.59
FCFY119.44%
OCF(TTM)3.1
OCFY143.02%
SpS15.99
BVpS16.16
TBVpS15.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.81%
ROE 4.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.15%
GM 39.47%
FCFM 16.21%
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.51
Debt/EBITDA 0.51
Cap/Depr 16.84%
Cap/Sales 3.2%
Interest Coverage N/A
Cash Conversion 120.61%
Profit Quality 390.68%
Current Ratio 1.3
Quick Ratio 1.25
Altman-Z 0.62
F-Score6
WACC6.83%
ROIC/WACCN/A
Cap/Depr(3y)55.47%
Cap/Depr(5y)123.43%
Cap/Sales(3y)5.01%
Cap/Sales(5y)6.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)542.07%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%277.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.65%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%26.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y176.2%
FCF growth 3YN/A
FCF growth 5Y30.19%
OCF growth 1Y219.77%
OCF growth 3Y25.73%
OCF growth 5Y19.86%